Emergent Biosolutions Email Format

Biotechnology Research
501-1,000 employees
Gaithersburg, MD, USA

Emergent Biosolutions is a biotechnology company that develops, manufactures, and delivers medical countermeasures and protections against public health threats worldwide.

Find contacts at Emergent Biosolutions

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

lastfirstinitial@ebsi.com

Company Overview

Industry
Biotechnology Research
Founded
1998
Headquarters
Gaithersburg, MD, USA
Revenue
$1B-$2.5B
FUNDING Stage
Public
Key Executives
Joseph C. Papa (President and Chief Executive Officer), Richard S. Lindahl (Executive Vice President, Chief Financial Officer), Howard Anderson (SVP & CIO)

Tech Stack

Akamai

Infrastructure

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Emergent BioSolutions?

Emergent BioSolutions uses the lastfirstinitial format, so Jane Smith would be smithj@ebsi.com.

What are the three operating segments of Emergent BioSolutions?

Emergent BioSolutions operates across three segments: Commercial Products, which includes NARCAN Nasal Spray and KLOXXADO Nasal Spray; MCM Products, covering anthrax and smallpox medical countermeasures; and a Bioservices segment offering contract development and manufacturing.

How does Emergent BioSolutions support the U.S. government's biodefense stockpile through its MCM Products segment?

Emergent BioSolutions supplies anthrax and smallpox medical countermeasures to the U.S. government and international partners, holding contracts with agencies such as BARDA to develop, manufacture, and procure these products for national preparedness stockpiles.

Who leads Emergent BioSolutions as President and CEO in 2026?

Joseph C. Papa serves as President and Chief Executive Officer of Emergent BioSolutions in 2026. He has been in the role since February 2024 and brings extensive experience from prior leadership positions in the pharmaceutical industry.

Can Clay help me find verified contacts at Emergent BioSolutions?

Yes. Clay can help you build a targeted list of Emergent BioSolutions contacts, verify email addresses against the lastfirstinitial@ebsi.com format, and enrich prospect records with role, department, and seniority data before outreach.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles